Table 3.

Peri-operative complications

BMI	<26 n = 170	26–40 n = 553	<40 n = 76	Total N = 799
Dindo–Clavien grading, n (%)
I	4 (2.4)	3 (0.5)	3 (3.8)	10 (1.3)
II	2 (1.2)	8 (1.4)	1 (1.3)	11 (1.4)
IIIa	0 (0.0)	5 (0.9)	0 (0.0)	5 (0.6)
IIIb	1 (0.6)	8 (1.4)	2 (2.6)	11 (1.4)
IV a	1 (0.6)	1 (0.2)	0 (0.0)	2 (0.3)
IV b	0 (0.0)	0 (0.0)	0 (0.0)	0 (0)
V	0 (0.0)	1 (0.2)	0 (0.0)	1 (0.1)
Minor- grade I & II, n (%)
Pain	3 (1.8)	3 (0.5)	1 (1.3)	7 (0.9)
Port site infection	1 (0.6)	6 (1.1)	2 (2.6)	8 (1.0)
ARF	0 (0.0)	0 (0.0)	1 (1.3)	1 (0.1)
Collection	0 (0.0)	2 (0.4)	0 (0.0)	2 (0.3)
DVT	0 (0.0)	0 (0.0)	1 (1.3)	1 (0.1)
Port site bleeding	1 (0.6)	0 (0.0)	0 (0.0)	1 (0.1)
Delirium	1 (0.6)	0 (0.0)	0 (0.0)	1 (0.1)
Major – grade III/IV/V, n (%)
Choledocholithiasis/pancreatitis	0 (0.0)	3 (0.5)	1 (1.3)	4 (0.5)
Bile leak	0 (0.0)	3 (0.5)	0 (0.0)	3 (0.4)
Bleeding	1 (0.6)	2 (0.4)	0 (0.0)	3 (0.4)
Collection	0 (0.0)	3 (0.5)	0 (0.0)	3 (0.4)
Papillary Stenosis	0 (0.0)	1 (0.2)	0 (0.0)	1 (0.1)
Respiratory distress/acidosis	1 (0.6)	0 (0.0)	0 (0.0)	1 (0.1)
Deranged LFT/ERCP	0 (0.0)	1 (0.2)	0 (0.0)	1 (0.1)
Mortality	0 (0.0)	1 (0.2)	0 (0.0)	1 (0.1)

ARF, acute renal failure; DVT, deep vein thrombosis; LFT, liver functioning test; ERCP, endoscopic retrograde cholangiopancreatography.